Syensqo announced that its Board of Directors approved the exploration of a potential dual listing of its shares in the United States of America, in addition to its existing Euronext Brussels listing.

During this exploratory phase, the Board of Directors will assess the feasibility and potential benefits of an additional listing, including the ability to increase Syensqo's visibility and expand its accessibility to North American investors.

Syensqo will communicate its decision when the evaluation is completed.

“As we complete our first full year of operations as a standalone company following our separation from Solvay, we are accelerating our transformation to become an even purer play specialty growth company. The Americas is Syensqo’s largest region, representing more than 40% of our sales and people, as well as being home to more than half our industrial footprint. In addition, as we expect a major part of our future growth and investments to be in this strategically important region, it makes sense for us to explore a U.S. listing, which has the potential added benefits of expanding and enhancing our investor base,” said Dr. Ilham Kadri, CEO, Syensqo.